A drug safety watchdog has renewed its criticism of the FDA's approval of a Parkinson's psychosis medication and is calling for stronger warnings on its label for patients and their families
A drug safety watchdog has renewed its criticism of the government's approval of a Parkinson's psychosis medication and is calling for stronger warnings on its label for patients and their families.
Deemed a"breakthrough" medication, Nuplazid received an expedited review and was approved by the Food and Drug Administration in 2016. The agency ruled that the potential benefits for a desperate patient population outweighed its risks, making it the only drug on the market approved to combat hallucinations and delusions in Parkinson's patients.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA takes up decades-long debate over breast implant safety
Read more »
Device-safety experts to FDA: Make data publicMedical device safety researchers are calling on the FDA to release hundreds of thousands of hidden injury and malfunction reports related to about 100 medical devices.
Read more »
FDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
Read more »
FDA proposes changes to mammography standards for first time in more than 20 yearsThe US Food and Drug Administration announced proposed changes Wednesday to mammography standards. The changes include providing information about dense breasts and strengthening ability to enforce standards.
Read more »
FDA proposes rule to notify women with dense breasts of higher cancer risk and imprecise mammogramsThe Food and Drug Administration is proposing a rule that would require doctors to tell women how dense breasts may influence the accuracy of their breast cancer screenings and encourage women with dense breasts to talk to a doctor.
Read more »
FDA proposes mammography rule to provide women with breast-density informationThe Food and Drug Administration proposes updating of 25-year-old mammography standards to help ensure women get breast density information
Read more »
FDA proposes mammography rule to provide women with information about breast densityThe FDA proposed requiring mammogram providers to notify women with dense breast tissue about how the condition could affect the accuracy of their mammograms and recommend they talk with doctors about whether they should have more tests to check for cancer
Read more »
FDA proposes mammogram changes for first time in 20 years to identify breast cancer earlyWomen with dense breasts will be notified that they are at a higher risk of developing breast cancer and that X-ray results aren't always as accurate for them.
Read more »
FDA Commissioner Calls for Tighter Standard for Approval of New Opioid DrugsFDA Commissioner Scott Gottlieb is proposing that the agency take the novel step of approving new opioid painkillers only if they show comparative advantages over existing drugs.
Read more »